NLS Pharmaceutics AG

NASDAQ:NLSP

4.15 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 0.5530.8981.6518.9481.3545.4317.0920.0940.1450.221.2250.007
Short Term Investments 000000000000
Cash and Short Term Investments 0.5530.8981.6518.9481.3545.4317.0920.0940.1450.221.2250.007
Net Receivables 0.0320.0110.0640.0410.060.0390.0430.0610.0130.0750.010
Inventory 0.2970-0.064-0.041-0.06-0.039-0.043-0.0610000
Other Current Assets 0.3110.9150.5940.2980.6680.2921.1490.1030.0630.0860.0840.083
Total Current Assets 1.1921.8232.2459.2462.0235.7238.2410.1970.2210.3821.3180.09
Non-Current Assets:
Property, Plant & Equipment, Net 0.0010.0070.0120.0180.0240.030.02800000
Goodwill 000000000000
Intangible Assets 000000000000
Goodwill and Intangible Assets 000000000000
Long Term Investments 00000000.0680.0560.0540.0550
Tax Assets 000000000000
Other Non-Current Assets -00.0170.0130.0120.0120.012-00.9470.3630.2600.055
Total Non-Current Assets 0.0010.0240.0250.030.0360.0420.0281.0150.4190.3150.0550.055
Total Assets 1.1931.8472.279.2772.0585.7658.2691.2120.640.6961.3740.146
Liabilities & Equity:
Current Liabilities:
Account Payables 4.5844.6343.1132.3732.5221.7370.5274.0062.7562.5091.8541.131
Short Term Debt 1.7141.634000.354-2,499.96901.7710.7930.690.6840.708
Tax Payables 000000000000
Deferred Revenue 1.14200002,499.96902,499.9690-000
Other Current Liabilities 0.2781.6520.7790.9860.5350.6660.666-2,498.5431.1720.8360.3820.576
Total Current Liabilities 7.7187.923.8923.363.4112.4031.1937.2044.7214.0352.922.415
Non-Current Liabilities:
Long Term Debt 00000000.3130.5750.15206.386
Deferred Revenue Non-Current 2.52.52.52.52.52.52.52.52.52.52.50
Deferred Tax Liabilities Non-Current 00000000-0000
Other Non-Current Liabilities 0.2440.2610.1650.1360.1890.3190.3270.1780.1780.180.1510.159
Total Non-Current Liabilities 2.7442.7612.6652.6362.6892.8192.8272.9923.2532.8322.6516.545
Total Liabilities 10.46210.686.5575.9966.15.2224.0210.1967.9746.8675.5718.959
Equity:
Preferred Stock 000000000000
Common Stock 0.8090.7330.7330.6690.4110.3440.260.1450.1450.1450.1450.134
Retained Earnings -72.409-70.373-65.814-58.201-50.347-41.706-34.363-29.76-28.13-26.898-24.866-21.451
Accumulated Other Comprehensive Income/Loss 0.004-0.158-0.066-0.051-0.033-0.152-0.18-0.019-0.019-0.019-0.011-0.011
Other Total Stockholders Equity 62.32860.96560.8660.86545.92742.05538.53220.6520.6720.60120.53512.515
Total Shareholders Equity -9.268-8.834-4.2873.281-4.0410.5424.249-8.984-7.334-6.171-4.197-8.814
Total Equity -9.268-8.834-4.2873.281-4.0410.5424.249-8.984-7.334-6.171-4.197-8.814
Total Liabilities & Shareholders Equity 1.1931.8472.279.2772.0585.7658.2691.2120.640.6961.3740.146